We report here a 34-month-old boy with global developmental delay referred for molecular karyotyping and fragile X studies. Molecular karyotype analysis revealed a microduplication in the 3p26.3 region involving part of the CHL1 and CNTN6 genes. Several deletions, one translocation, and one duplication have previously been described in this region of chromosome 3. The CHL1 gene has been proposed as a dosage-sensitive gene with a central role in cognitive development, and so the microduplication reported here appears to be implicated in our patient’s phenotype. 1. Introduction Anomalies of the distal portion of the short arm of chromosome 3 are rare and not yet fully understood. The most well-characterised anomalies are deletions. For the most part, they occur de novo, although a few familial cases have been reported [1–8]. These deletions range from one to several megabases, but the extent of the deletion does not correlate with phenotypic severity. The clinical syndrome includes intellectual disability, low birth weight, micro- and trigonocephaly, and characteristic facial features such as ptosis, telecanthus, downslanting palpebral fissures, and micrognathia. Many genes have been implicated to play a role: CRBN and CNTN4 have been suggested to cause typical 3p deletion syndrome [9, 10], and the CHL1 gene has been proposed to play an additional role in cognitive impairment [8, 11–13]. The involvement of the CHL1 gene has been reported in four previous case studies: three with deletions confined to 3p26.3 [6–8], including only the CHL1 gene, a translocation [12], and one novel microduplication [13] (Figure 1). In these cases the growth abnormalities and typical facial features of 3p deletion syndrome were absent. Nonspecific intellectual disability was the main trait. Figure 1: Schematic of chromosome 3p26.3 showing microdeletions and microduplications. (a) Shows the ideogram of chromosome 3, together with the region encompassing microdeletions and microduplications (red box). (b) Shows the location and extent of the microdeletions and microduplications detected in the proband reported here and other cases reported in the literature [ 6– 8, 13], BAC probes used in the FISH studies, and RefSeq genes that lie within this region of chromosome 3. These graphics were taken from the UCSC genome browser [ 14]. Interestingly, the previously reported 3p26.3 microduplication case manifested similar clinical features to those patients carrying a CHL1 gene deletion, namely, nonspecific intellectual disability and epilepsy [13]. Epilepsy was also present in one
References
[1]
M. Verjaal and M. B. De Nef, “A patient with a partial deletion of the short arm of chromosome 3,” American Journal of Diseases of Children, vol. 132, no. 1, pp. 43–45, 1978.
[2]
K. Narahara, K. Kikkawa, M. Murakami et al., “Loss of the 3p25.3 band is critical in the manifestation of del(3p) syndrome: karyotype-phenotype correlation in cases with deficiency of the distal portion of the short arm of chromosome 3,” American Journal of Medical Genetics, vol. 35, no. 2, pp. 269–273, 1990.
[3]
S. Kariya, K. Aoji, H. Akagi et al., “A terminal deletion of the short arm of chromosome 3: karyotype 46, XY, del (3) (p25-pter); a case report and literature review,” International Journal of Pediatric Otorhinolaryngology, vol. 56, no. 1, pp. 71–78, 2000.
[4]
C. B. Cargile, D. L.-M. Goh, B. K. Goodman et al., “Molecular cytogenetic characterization of a subtle interstitial del(3)(p25.3p26.2) in a patient with deletion 3p syndrome,” American Journal of Medical Genetics, vol. 109, no. 2, pp. 133–138, 2002.
[5]
C.-P. Chen, S.-P. Lin, C.-S. Ho et al., “Distal 3p monosomy associated with epilepsy in a boy,” Genetic Counseling, vol. 16, no. 4, pp. 429–432, 2005.
[6]
C. Cuoco, P. Ronchetto, S. Gimelli et al., “Microarray based analysis of an inherited terminal 3p26.3 deletion, containing only the CHL1 gene, from a normal father to his two affected children,” Orphanet Journal of Rare Diseases, vol. 6, no. 1, article 12, 2011.
[7]
P. Pohjola, N. de Leeuw, M. Penttinen, and H. K??ri?inen, “Terminal 3p deletions in two families—correlation between molecular karyotype and phenotype,” American Journal of Medical Genetics A, vol. 152, no. 2, pp. 441–446, 2010.
[8]
C.-P. Chen, Y.-N. Su, C.-Y. Hsu et al., “Mosaic deletion-duplication syndrome of chromosome 3: prenatal molecular cytogenetic diagnosis using cultured and uncultured amniocytes and association with fetoplacental discrepancy,” Taiwanese Journal of Obstetrics and Gynecology, vol. 50, no. 4, pp. 485–491, 2011.
[9]
T. Fernandez, T. Morgan, N. Davis et al., “Disruption of contactin 4 (CNTN4) results in developmental delay and other features of 3p deletion syndrome,” American Journal of Human Genetics, vol. 74, no. 6, pp. 1286–1293, 2004.
[10]
T. Dijkhuizen, T. van Essen, P. van der Vlies et al., “FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions,” American Journal of Medical Genetics A, vol. 140, no. 22, pp. 2482–2487, 2006.
[11]
M.-H. Wei, I. Karavanova, S. V. Ivanov et al., “In silico-initiated cloning and molecular characterization of a novel human member of the L1 gene family of neural cell adhesion molecules,” Human Genetics, vol. 103, no. 3, pp. 355–364, 1998.
[12]
S. G. M. Frints, P. Marynen, D. Hartmann et al., “CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior,” Human Molecular Genetics, vol. 12, no. 13, pp. 1463–1474, 2003.
[13]
M. Shoukier, S. Fuchs, E. Schawibold et al., “Microduplication of 3p26. 3 in nonsyndromic intellectual disability indicates an important role of CHL1 for normal cognitive function,” Neuropediatrics, vol. 44, pp. 268–271, 2013.
[14]
University of California Santa Cruz (UCSC) Genome Browser, http://genome.ucsc.edu/.
[15]
Online Mendelian Inheritance in Man (OMIM) database, http://www.ncbi.nlm.nih.gov/omim.
[16]
D. Pinkel, T. Straume, and J. W. Gray, “Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 83, no. 9, pp. 2934–2938, 1986.
[17]
Ministry of Health Growth Charts, http://www.health.govt.nz/our-work/life-stages/child-health/well-child-tamariki-ora-services/growth-charts.
[18]
S. Solidin, B. Brugnara, and E. Wong, Pediatric Reference Ranges, American Association for Clinical Chemistry, 4th edition, 2003.
[19]
E. Doherty, R. O’Connor, A. Zhang et al., “Developmental delay referrals and the roles of Fragile X testing and molecular karyotyping: a New Zealand perspective,” Molecular Medicine Reports, vol. 7, no. 5, pp. 1710–1714, 2013.
[20]
Y. Takeda, K. Akasaka, S. Lee et al., “Impaired motor coordination in mice lacking neural recognition molecule NB-3 of the contactin/F3 subgroup,” Journal of Neurobiology, vol. 56, no. 3, pp. 252–265, 2003.
[21]
A. Zuko, K. T. Kleijer, A. Oguro-Ando et al., “Contactins in the neurobiology of autism,” European Journal of Pharmacology, vol. 719, no. 1–3, pp. 63–74, 2013.
[22]
T. Dijkhuizen, T. van Essen, P. van der Vlies et al., “FISH and array-CGH analysis of a complex chromosome 3 aberration suggests that loss of CNTN4 and CRBN contributes to mental retardation in 3pter deletions,” American Journal of Medical Genetics A, vol. 140, no. 22, pp. 2482–2487, 2006.
[23]
B. Conrad and S. E. Antonarakis, “Gene duplication: a drive for phenotypic diversity and cause of human disease,” Annual Review of Genomics and Human Genetics, vol. 8, pp. 17–35, 2007.
C. Barbosa, I. Peixeiro, and L. Rom?o, “Gene expression regulation by upstream open reading frames and human disease,” PLoS Genetics, vol. 9, no. 8, Article ID e1003529, 2013.
[26]
H. M. Kearney, J. B. Kearney, and L. K. Conlin, “Diagnostic implications of excessive homozygosity detected by SNP-Based microarrays: consanguinity, uniparental disomy, and recessive single-gene mutations,” Clinics in Laboratory Medicine, vol. 31, no. 4, pp. 595–613, 2011.